• India

Indian Life Sciences Stocks Analysis

NSEI:SYNGENE
NSEI:SYNGENE
NSEI:SYNGENELife Sciences

Syngene International (NSE:SYNGENE) jumps 3.6% this week, though earnings growth is still tracking behind five-year shareholder returns

June 24, 2022
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...
NSEI:DCAL
NSEI:DCAL
NSEI:DCALLife Sciences

Dishman Carbogen Amcis (NSE:DCAL) Use Of Debt Could Be Considered Risky

June 22, 2022
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
NSEI:VIMTALABS
NSEI:VIMTALABS
NSEI:VIMTALABSLife Sciences

Vimta Labs Limited (NSE:VIMTALABS) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

June 12, 2022
It looks like Vimta Labs Limited ( NSE:VIMTALABS ) is about to go ex-dividend in the next 3 days. The ex-dividend date...
NSEI:DIVISLAB
NSEI:DIVISLAB
NSEI:DIVISLABLife Sciences

Have Divi's Laboratories Limited (NSE:DIVISLAB) Insiders Been Selling Their Stock?

June 12, 2022
Investors may wish to note that an insider of Divi's Laboratories Limited , S. Rao, recently netted ₹7.3m from selling...
NSEI:BROOKS
NSEI:BROOKS
NSEI:BROOKSLife Sciences

Does Brooks Laboratories (NSE:BROOKS) Have A Healthy Balance Sheet?

June 10, 2022
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
NSEI:TARSONS
NSEI:TARSONS
NSEI:TARSONSLife Sciences

Tarsons Products' (NSE:TARSONS) Promising Earnings May Rest On Soft Foundations

June 04, 2022
Tarsons Products Limited's ( NSE:TARSONS ) robust earnings report didn't manage to move the market for its stock. Our...
NSEI:VIMTALABS
NSEI:VIMTALABS
NSEI:VIMTALABSLife Sciences

Vimta Labs (NSE:VIMTALABS) Is Due To Pay A Dividend Of ₹2.00

June 02, 2022
Vimta Labs Limited's ( NSE:VIMTALABS ) investors are due to receive a payment of ₹2.00 per share on 25th of July. This...
NSEI:SYNGENE
NSEI:SYNGENE
NSEI:SYNGENELife Sciences

Declining Stock and Decent Financials: Is The Market Wrong About Syngene International Limited (NSE:SYNGENE)?

June 01, 2022
Syngene International (NSE:SYNGENE) has had a rough month with its share price down 8.7%. But if you pay close...
NSEI:DIVISLAB
NSEI:DIVISLAB
NSEI:DIVISLABLife Sciences

Divi's Laboratories' (NSE:DIVISLAB) five-year total shareholder returns outpace the underlying earnings growth

May 27, 2022
Divi's Laboratories Limited ( NSE:DIVISLAB ) shareholders have seen the share price descend 24% over the month. But...
  • 1
  • 2
  • 3
  • 4
  • 5
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Company
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.